Substance P prohormones were identified in the caudate nucleus, hypothalamus, and substantia nigra of human brain. A polypeptide fraction of acidic brain extracts was fractionated on Sephadex G-50. The Iyophilized fractions were sequentially treated with trypsin and a substance Pdegrading enzyme with strong preference toward the Phe7-Phe' and Phe8-Gly9 bonds. The released substance P(1-7) fragment was isolated by ion-exchange chromatography and quantitated by a specific radioimmunoassay. Confirmation of the structure of the isolated radioimmunoassay-active fragment was achieved by electrophoresis and HPLC. By using this enzymatic/radioimmunoassay procedure, two polypeptide fractions of apparent M, 5000 and 15,000, respectively, were identified. The latter component was the majior one of the two but was estimated to account for only about 5% of total substance P radioimmunoassay activity. Because it is of the size predicted from the nucleotide sequences of cDNA for substance P prohormones in bovine brain, the Mr 15,000 component may represent the full-length prohormone.
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glycine (19) . Enzymes involved in the processing of the precursors are incompletely known.
The present paper reports the identification of substance P precursors in human brain. The strategy for the experimental approach is based on the enzymatic generation in vitro of a unique peptide fragment (20, 21) . Trypsin treatment of any product of the preprotachykinins containing the substance P sequence generates a fragment with the NH2-terminal region identical with that of the native peptide. Further conversion of this fragment with an endopeptidase capable of hydrolyzing substance P at the Phe7-Phe8 bond releases the substance P(1-7) sequence as a fragment that can be recovered by ion-exchange chromatography and quantitated by a specific radioimmunoassay (RIA) (Fig. 1 ). This procedure was used to identify substance P-containing polypeptide fractions in human caudate nucleus, hypothalamus, and substantia nigra. A partial sequence of a protachykinin in bovine brain was recently reported (22) .
The primary structure of the undecapeptide substance P was determined in 1971 (1). This knowledge greatly facilitated studies on its putative role as neurotransmitter or neuromodulator. Within the central nervous system, substance P has been localized in various nerve fibers (2-5) and in cellular organelles from nerve endings (6-9). Substance P is released from nerve tissue within the central nervous system by depolarizing stimuli (7, 8, 10, 11) and can alter the activity of certain neurons when applied in their vicinity (12) (13) (14) . However, until recently very little was known about the biosynthesis of substance P.
Substance P belongs to a family of structurally related peptides, the tachykinins (15) . Peptides in this family exhibit biological activities similar to those of substance P and share a common COOH-terminal sequence, Phe-Xaa-Gly-LeuMet-NH2, the COOH-terminal residue of which is amidated. The NH2-terminal sequence is unique for each peptide and accounts for its specific action. In addition to substance P, only a few other members of the tachykinin family have been identified in mammalian tissue (16, 17) . The primary structures of two types of precursors of substance P from bovine brain were deduced by the use of cDNA technology (18): a-preprotachykinin contains a single substance P sequence whereas f3-preprotachykinin contains not only substance P but also a kassinin-like sequence, neurokinin A (substance K). In the precursors, each tachykinin sequence is followed at the COOH-terminus by a glycine residue and is flanked by pairs of basic amino acid residues, Arg-Arg or Lys-Arg (Fig.  1) . The generation of substance P from its precursor probably occurs in several steps leading to the liberation of a dodecapeptide, which would yield the amidated undecapeptide upon enzymatic conversion of the COOH-terminal MATERIALS AND METHODS Materials. Human caudate nucleus, hypothalamus, and substantia nigra were removed at autopsy and stored frozen at -80'C before use. SP-Sephadex C-25, Sephadex G-50, and Agarose C were obtained from Pharmacia. All reference peptides were from Peninsula Laboratories (San Carlos, CA) except for the substance P(1-7), -(3-7), and -(1-8) fragments, which were prepared by J. M. Stewart (Department of Biochemistry, University of Colorado, Denver). L-1-Tosylamido-2-phenylethyl chloromethyl ketone (TPCK)-treated trypsin and the protein standards used for column calibration in the gelfiltration experiments were from Sigma or from KABI Diagnostica (Stockholm, Sweden; '2-I-labeled human prolactin). All other chemicals and solvents were of reagent grade.
Enzyme Preparation. The enzyme activity capable of hydrolyzing substance P at the Phe7-Phe8 bond was purified from human cerebrospinal fluid by fractionation on DEAESepharose CL-6B, Sephadex G-100, and Sephacryl S-200 as described (23) . The cerebrospinal fluid specimens were obtained from a number of neurologic patients. The recovered enzyme (apparent Mr 40,000) was characterized as an endopeptidase with high specificity for substance P, with no activity against, for instance, neurokinin A. Substance P(1-7) and - (1) (2) (3) (4) (5) (6) (7) (8) fragments are formed at a constant 3:2 ratio over time (23) . The endopeptidase was obtained in a yield of about 1 ,ug/ml of cerebrospinal fluid and had an apparent Km of 20 uM for the generation of the substance P(1-7) fragment.
Recovery of Polypeptide Fractions from Brain Tissues. The frozen brain tissues (5-12 g of caudate or hypothalamus, 1-2 g of substantia nigra) were thawed and homogenized in 1 M acetic acid (20 ml/g of tissue) at 90°C as described (24 Arg-Pro-Lys-Pro-Gln-Gln-Phe Ag) of the cerebrospinal fluid enzyme was followed by a 2-hr incubation at 370C before the reaction was terminated as before.
The SP-Sephadex fractionation procedure was repeated except that the eluate was collected at a lower buffer concentration (0.8 M). Fractions were dried and then were analyzed by radioimmunoassay.
Identification of Substance P(1-7) by Electrophoresis and HPLC. Samples were electrophoresed in 1.0 cm x 65-cm columns of agarose suspension, according to a published procedure (26) . Electrophoresis was in acidic pH at 1200 V and 15 mA for 5 hr. Aliquots (0.5 ml) of the suspensions were eluted and subjected to radioimmunoassay. HPLC was performed in a Hewlett-Packard 1084B liquid chromatograph with a Waters ,uBondapak C18 column (4.5 x 250 mm). Samples were eluted with a 40-min linear 15-30% gradient of methanol in 0.04% trifluoroacetic acid followed by 30% methanol/0.04% trifluoroacetic acid. Fractions of 1 ml were collected at a flow rate of 1 ml/min, evaporated, and analyzed by radioimmunoassay. The HPLC column and the electrophoresis system were calibrated by using substance P and its 1-7, 3-7, 3-11, and 5-11 fragments as markers.
Radioimmunoassay. The radioimmunoassay for substance P(1-7) was described previously (24) . 3H-labeled substance P(1-7) was used as tracer with antiserum that had been raised in rabbits against the peptide-thyroglobulin conjugate. The antiserum gave about 1% crossreactivity with substance P(1-8), whereas its crossreactivity with substance P and other substance P fragments was <0.2%. Fig. 2A illustrates the elution pattern from a Sephadex G-50 column of substance P(1-7)-containing peptides in a crude hypothalamus extract. There are two fractions ofapparent Mr 15,000 and 5000, respectively, whereas the bulk of substance P(1-7) activity was recovered in the low Mr region of authentic substance P and its 1-7 fragment. Repetitive gelfiltration runs of hypothalamic material yielded similar distributions, with some quantitative variations among the individual patients. In a separate experiment, where the extract was fractionated on a SP-Sephadex column prior to Sephadex G-50 chromatography, an additional substance P(1-7)-containing component of Mr -2000 was distinguished in addition to the Mr 5000 species (Fig. 2B) . Sephadex G-50 chromatography ofextracts from human caudate nucleus and substantia nigra yielded elution profiles in conformity with those shown in Fig. 2A . The substance P(1-7) activity recovered from the higher Mr fractions was always much lower than that from the low Mr region. For instance, the experiment shown in Fig. 2A precursor represents only about 5% of the total substance P(1-7)-containing peptides, based on radioimmunoassay activity. Experiments performed with synthetic substance P showed that the cerebrospinal fluid enzyme can convert, at most, 40% of the peptide to its 1-7 fragment. The yield from picomole amounts of synthetic substance P over the whole degradation procedure, including trypsin treatment and SPSephadex fractionation, did not exceed 10%. With nanomole amounts, the yield improved to about 25% for both substance P and the substance P-glycine derivative.
RESULTS
Results from HPLC analysis of the products reacting in the substance P(1-7) radioimmunoassay are given in Fig. 3 . The activity derived from the Mr 15,000 component from the various brain areas was eluted at the same position as the synthetic heptapeptide. HPLC of the activity liberated by enzyme treatment of the Mr 5000 species gave the same result.
Analytical electrophoresis also confirmed the identity of the substance P(1-7) fragment liberated from the Mr 15,000 fraction from hypothalamus (Fig. 4) . The same observation was made for the corresponding material recovered from caudate nucleus extracts.
DISCUSSION
To identify all possible substance P peptides and particularly larger precursors, we developed a two-step enzymatic procedure with isolation by ion-exchange chromatography both of an intermediate tridecapeptide, formed by trypsin treatment, and of the final product, substance P(1- treatment with a highly selective endopeptidase. The concentration of generated substance P(1-7) was quantified by radioimmunoassay, and its structural identity was confirmed by two independent analytical techniques. In control experiments, trypsin treatment did not affect substance P or the 1-7 fragment. Since the procedure has a series of critical steps, it should have the desired specificity. The substance P endopeptidase was chosen because of its specificity and potency.
The size and structure of the bovine prohormones for substance P have been predicted from cDNA sequences (18) . Corresponding information for the human prohormones is not available. Assuming cross-species structure conservation, the Mr 15,000 fraction may represent the full sequence of a-or (-protachykinin, whereas the Mr 2000 and 5000 fractions may represent shorter intermediates in the processing of the precursor containing the substance P unit. As in other peptide precursors, the proteolytic processing probably occurs at pairs of basic amino acid residues that flank the mature hormone sequence. If this is the case and if the Mr 5000 species found in the human brain is an incomplete cleavage product(s) of preprotachykinin, then that species is likely to consist of substance P plus COOH-terminal flanking sequence (e.g., corresponding to the residues 58-108 in the bovine prohormones; see Fig. 1 ). It should be noted that our molecular weight estimates are tentative and may be overestimated by as much as 20% in the region above Mr 10,000.
The radioimmunoassay analysis indicates that the precursor fractions identified in human brain represent only a small fraction of total substance P-related peptides. This is compatible with studies of labeled amino acid incorporation into substance P in vivo that indicate a rapid turnover of precursor. Four hours after a pulse of labeled amino acids, radioactivity is recovered in the mature peptide (27) . The heptapeptide released from the Mr 15,000 material, 0.5 pmol/g of tissue, represents about 5% of all activity generated from the tissue. However, considering the comparatively modest yield of the enzyme degradation procedure, it is likely that the true concentration is at least 10 times higher. This would also be true for the activity that was coeluted with substance P (Fig. 2A) . In fact, the substance P(1-7) activity recovered in the low molecular weight region by the enzymatic procedure only represented about a tenth of that determined by direct radioimmunoassay of substance P. Postmortem changes may have affected the relative concentrations of the precursor forms. However, there was no significant difference between tissues obtained 10 and 30 hr after death.
The method described here should allow studies of the regulation of biosynthesis of the substance P precursor and the mechanisms of precusor processing.
